Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: Development of a tool for clinical decision-making

BJU International

Volumn 117, Issue 2, 2016, Pages 272-279

  Aziz, Atiqullah ^a   Shariat, Shahrokh F ^k   Roghmann, Florian ^b   Brookman May, Sabine ^c   Stief, Christian G ^c   Rink, Michael ^a   Chun, Felix K ^a   Fisch, Margit ^a   Novotny, Vladimir ^d   Froehner, Michael ^d   Wirth, Manfred P ^d   Schnabel, Marco J ^e   Fritsche, Hans Martin ^e   Burger, Maximilian ^e   Pycha, Armin ^l   Brisuda, Antonin ^m   Babjuk, Marko ^m   Vallo, Stefan ^f   Haferkamp, Axel ^f   Roigas, Jan ^g   Noldus, Joachim ^b   Stredele, Regina ^h   Volkmer, Björn ^h   Bastian, Patrick J ⁱ   Xylinas, Evanguelos ⁿ   May, Matthias ^j   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f GOETHE UNIVERSITY   (Germany)

^g Vivantes Kliniken for Gynaecologic and Obstetrics Am Urban and im Friedrichshain   (Germany)

^h Department of Pathology   (Germany)

ⁱ Golzheim Paracelsus Clinic   (Germany)

^j St Elisabeth Clinic Straubing   (Germany)

^k MEDICAL UNIVERSITY OF VIENNA   (Austria)

^l CENTRAL HOSPITAL OF BOLZANO   (Italy)

^m UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

ⁿ Institut Cochin   (France)

more..

Author keywords

bladder cancer; mortality; nomograms; outcome; radical cystectomy

Indexed keywords

AGED; ARTICLE; BLADDER CARCINOMA; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOMOGRAM; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEX DIFFERENCE; SURVIVAL PREDICTION; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; CANCER STAGING; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIAL; EPIDEMIOLOGY; EUROPE; MIDDLE AGED; MORTALITY; NORTH AMERICA; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; URINARY BLADDER NEOPLASMS; VALIDATION STUDY;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CLINICAL DECISION-MAKING; CYSTECTOMY; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NOMOGRAMS; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84954388334     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12984     Document Type: Article

References (26)

1. Witjes JA, Compérat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014; 65: 778-792
2. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006; 12: 6663-6676
3. Bochner BH, Kattan MW, Vora KC, International Bladder Cancer Consortium. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006; 24: 3967-3972
4. May M, Bastian PJ, Brookman-May S, et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol 2013; 31: 1141-1147
5. Shariat SF, Capitanio U, Jeldres C, Karakiewicz PI,. Can nomograms be superior to other prediction tools? BJU Int 2009; 103: 492-495; discussion 495-7
6. Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW,. An updated catalog of prostate cancer predictive tools. Cancer 2008; 113: 3075-3099
7. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW,. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res 2008; 14: 4400-4407
8. Greene FL, Page DL, Flemming ID,. American Joint Committee on Cancer Staging Manual, Sixth edn. New York: Springer-Verlag, 2009
9. Algaba F,. Lymphovascular invasion as a prognostic tool for advanced bladder cancer. Curr Opin Urol 2006; 16: 367-371
10. Rink M, Fajkovic H, Cha EK, et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 2012; 61: 854-855
11. Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387
12. Hens N, Aerts M, Molenberghs G,. Model selection for incomplete and design-based samples. Stat Med 2006; 25: 2502-2520.
13. Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574
14. Aziz A, May M, Burger M, et al. The PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014; 66: 156-163
15. Kluth LA, Rieken M, Xylinas E, et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. Eur Urol 2013; 66: 913-919
16. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013; 63: 234-241
17. Shariat SF, Svatek RS, Tilki D, et al. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int 2010; 105: 1402-1412
18. Meeks JJ, Bellmunt J, Bochner BH, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 2012; 62: 523-533
19. May M, Herrmann E, Bolenz C, et al. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 2011; 59: 712-718
20. Shariat SF, Rink M, Ehdaie B, et al. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol 2013; 63: 371-378
21. Xylinas E, Rink M, Novara G, et al. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol 2013; 20: 1027-1034
22. Nuhn P, May M, Sun M, et al. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol 2012; 61: 58-64
23. Zaak D, Burger M, Otto W, et al. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU Int 2010; 106: 342-348
24. Tilki D, Svatek RS, Karakiewicz PI, et al. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol 2010; 183: 87-93
25. Liberman D, Alasker A, Sun M, et al. Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int 2011; 107: 905-911
26. Burger M, Mulders P, Witjes W,. Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 2012; 61: 1070-1071